SCHEMBL30640468

SCHEMBL30640468

Cc1cc(Br)c2ccccc2c1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.61
CYP2A6 P11509 5/20 0.61
TDP1 Q9NUW8 3/20 0.44
MAOB P27338 1/20 0.44
ALDH1A1 P00352 7/20 0.41
HSD17B10 Q99714 3/20 0.41
HIF1A Q16665 1/20 0.41
CYP1B1 Q16678 1/20 0.41
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HPGD P15428 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.38
TSHR P16473 2/20 0.37
TRPM4 Q8TD43 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2519793 1.00 CYP1A2 (0.61) CYP1A2CYP2A6TDP1MAOBALDH1A1
SCHEMBL28995951 0.92 CYP1A2 (0.53) CYP1A2CYP2A6TDP1MAOBALDH1A1
SCHEMBL29524488 0.76 CYP2A6 (0.48) CYP1A2CYP2A6TDP1ALDH1A1HSD17B10
SCHEMBL598829 0.76 CYP1A2 (1.00) CYP1A2CYP2A6TDP1ALDH1A1HSD17B10
SCHEMBL29352143 0.76 CYP1A2 (1.00) CYP1A2CYP2A6TDP1ALDH1A1HSD17B10
SCHEMBL7949503 0.76 CYP2A6 (0.67) CYP1A2CYP2A6TDP1MAOBALDH1A1
SCHEMBL3103031 0.76 CYP2A6 (0.48) CYP1A2CYP2A6TDP1ALDH1A1HSD17B10
SCHEMBL7822962 0.76 CYP1A2 (0.63) CYP1A2CYP2A6TDP1MAOBALDH1A1
SCHEMBL13755384 0.74 CYP1A2 (0.46) CYP1A2CYP2A6TDP1ALDH1A1HSD17B10
Ammonia Solution, Strong SCHEMBL27919233 0.74 CYP1A2 (0.95) CYP1A2CYP2A6TDP1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025128805-A1 A CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS MERCK SHARP & DOHME LLC (US) 2025-06-19 WO disclosed
WO-2023214325-A1 PYRAZOLOPYRIMIDINE DERIVATIVES AND USES THEREOF AS TET2 INHIBITORS NOVARTIS AG (CH) 2023-11-09 WO disclosed